IS6196A - Púrín afleiður - Google Patents

Púrín afleiður

Info

Publication number: IS6196A
Authority: IS; Iceland
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-06-15

Application number

IS6196A

Other languages

English (en)

Inventor

John Mantell Simon

Marina Monaghan Sandra

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-15

Filing date

2001-12-11

Publication date

2001-12-11

2001-12-11 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2001-12-11 Publication of IS6196A publication Critical patent/IS6196A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Oncology (AREA)

IS6196A 1999-06-15 2001-12-11 Púrín afleiður IS6196A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9913932.1A GB9913932D0 (en)	1999-06-15	1999-06-15	Purine derivatives
PCT/IB2000/000789 WO2000077018A2 (en)	1999-06-15	2000-06-13	Purine derivatives

Publications (1)

Publication Number	Publication Date
IS6196A true IS6196A (is)	2001-12-11

Family

ID=10855403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6196A IS6196A (is)	1999-06-15	2001-12-11	Púrín afleiður

Country Status (39)

Country	Link
US (2)	US6900309B1 (is)
EP (1)	EP1185542A2 (is)
JP (1)	JP2003502339A (is)
KR (1)	KR20020010707A (is)
CN (1)	CN1179970C (is)
AP (1)	AP2001002361A0 (is)
AR (1)	AR024345A1 (is)
AU (1)	AU764106B2 (is)
BG (1)	BG106289A (is)
BR (1)	BR0011705A (is)
CA (1)	CA2379786C (is)
CZ (1)	CZ20014397A3 (is)
DZ (1)	DZ3168A1 (is)
EA (1)	EA004861B1 (is)
EC (1)	ECSP003531A (is)
EE (1)	EE200100681A (is)
GB (1)	GB9913932D0 (is)
GT (1)	GT200000096A (is)
HK (1)	HK1047111A1 (is)
HN (1)	HN2000000097A (is)
HR (1)	HRP20010927A2 (is)
HU (1)	HUP0203419A3 (is)
IL (1)	IL147098A0 (is)
IS (1)	IS6196A (is)
MA (1)	MA26799A1 (is)
MX (1)	MXPA01013094A (is)
NO (1)	NO20016109L (is)
NZ (1)	NZ516094A (is)
OA (1)	OA11968A (is)
PA (1)	PA8497001A1 (is)
PE (1)	PE20010430A1 (is)
PL (1)	PL354367A1 (is)
SK (1)	SK18192001A3 (is)
SV (1)	SV2001000100A (is)
TN (1)	TNSN00133A1 (is)
TR (1)	TR200103607T2 (is)
UY (1)	UY26204A1 (is)
WO (1)	WO2000077018A2 (is)
ZA (1)	ZA200110208B (is)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2264826T3 (es) *	1998-10-16	2007-01-16	Pfizer Inc.	Derivados de adenina.
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
GB9924361D0 (en)	1999-10-14	1999-12-15	Pfizer Ltd	Purine derivatives
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
US6753322B2 (en) *	2000-06-06	2004-06-22	Pfizer Inc	2-aminocarbonyl-9H-purine derivatives
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
GB0104555D0 (en) *	2001-02-23	2001-04-11	Glaxo Group Ltd	New Therapeutic method
WO2002072067A2 (en) *	2001-03-12	2002-09-19	Glaxo Group Limited	Pharmaceutical aerosol formulation
GB0129273D0 (en)	2001-12-06	2002-01-23	Pfizer Ltd	Crystalline drug form
GB0129397D0 (en) *	2001-12-07	2002-01-30	Pfizer Ltd	Pharmaceutical combination
GB0228723D0 (en)	2002-12-09	2003-01-15	Cambridge Biotechnology Ltd	Treatment of pain
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
JPWO2005019238A1 (ja) *	2003-08-22	2006-10-19	明治製菓株式会社	新規アザライド及びアザラクタム誘導体とその製造法
JP2005132767A (ja) *	2003-10-30	2005-05-26	Sumitomo Chemical Co Ltd	プリン化合物の製造方法
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
TWI346109B (en) *	2004-04-30	2011-08-01	Otsuka Pharma Co Ltd	4-amino-5-cyanopyrimidine derivatives
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0500785D0 (en) *	2005-01-14	2005-02-23	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
EP2532679B1 (en)	2005-10-21	2017-04-12	Novartis AG	Human antibodies against il13 and therapeutic uses
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
US7732595B2 (en) *	2006-02-03	2010-06-08	Gilead Palo Alto, Inc.	Process for preparing an A2A-adenosine receptor agonist and its polymorphs
JP2010504933A (ja)	2006-09-29	2010-02-18	ノバルティスアーゲー	Ｐｉ３ｋ脂質キナーゼ阻害剤としてのピラゾロピリミジン
US20100041662A1 (en)	2006-10-30	2010-02-18	Sandrine Ferrand	Heterocyclic compounds as antiinflammatory agents
ES2442930T3 (es)	2008-01-11	2014-02-14	Novartis Ag	Pirimidinas como inhibidores de cinasas
PL2391366T3 (pl)	2009-01-29	2013-04-30	Novartis Ag	Podstawione benzimidazole do leczenia gwiaździaków
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
MX2012001838A (es)	2009-08-12	2012-02-29	Novartis Ag	Compuestos de hidrazona heterociclico y sus usos para tratar cancer e inflamacion.
CN102573846B (zh)	2009-08-17	2015-10-07	因特利凯公司	杂环化合物及其用途
MX2012002179A (es)	2009-08-20	2012-03-16	Novartis Ag	Compuestos heterociclicos de oxima.
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
US8637516B2 (en)	2010-09-09	2014-01-28	Irm Llc	Compounds and compositions as TRK inhibitors
JP2014505088A (ja)	2011-02-10	2014-02-27	ノバルティスアーゲー	Ｃ−ＭＥＴチロシンキナーゼ阻害剤としての［１，２，４］トリアゾロ［４，３−ｂ］ピリダジン化合物
EP2678016B1 (en)	2011-02-23	2016-08-10	Intellikine, LLC	Heterocyclic compounds and uses thereof
US9102671B2 (en)	2011-02-25	2015-08-11	Novartis Ag	Compounds and compositions as TRK inhibitors
MX339302B (es)	2011-09-15	2016-05-19	Novartis Ag	3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina.
US9174994B2 (en)	2011-11-23	2015-11-03	Intellikine, Llc	Enhanced treatment regimens using mTor inhibitors
US20150297604A1 (en)	2012-04-03	2015-10-22	Novartis Ag	Combination Products with Tyrosine Kinase Inhibitors and their Use
CA2906542A1 (en)	2013-03-15	2014-09-25	Intellikine, Llc	Combination of kinase inhibitors and uses thereof
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
MX2017001461A (es)	2014-07-31	2017-05-11	Novartis Ag	Terapia de combinacion.
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en)	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
JPS55153789A (en) *	1979-04-11	1980-11-29	Sankyo Co Ltd	Penem-3-carboxylic acid derivative and its preparation
JPS55153798A (en) *	1979-05-18	1980-11-29	Kikkoman Corp	Novel 2-substituted-adenosine 3',5'-cyclic phosphate and its preparation
JPH0313934A (ja) *	1989-06-12	1991-01-22	Konica Corp	ハロゲン化銀写真感光材料
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5705491A (en)	1992-10-27	1998-01-06	Nippon Zoki Pharmaceutical Co., Ltd.	Adenosine deaminase inhibitor
DK155292D0 (da)	1992-12-23	1992-12-23	Novo Nordisk As	Kemiske forbindelser, deres fremstilling og anvendelse
JP3362291B2 (ja) *	1993-10-06	2003-01-07	コニカ株式会社	ハロゲン化銀写真感光材料及び画像形成方法
DK0820323T3 (da) *	1995-04-14	2003-11-24	Smithkline Beecham Corp	Inhalator til afmålte doser af salmeterol
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
ZA9810490B (en)	1997-12-03	1999-05-20	Dainippon Pharmaceutical Co	2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
US6232297B1 (en)	1999-02-01	2001-05-15	University Of Virginia Patent Foundation	Methods and compositions for treating inflammatory response
RU2258071C2 (ru)	1999-05-24	2005-08-10	Юниверсити Оф Вирджиния Пэйтент Фаундейшн	Производные 2-алкиниладенозина для борьбы с воспалительной реакцией
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
GB0003960D0 (en) *	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives

1999
- 1999-06-15 GB GBGB9913932.1A patent/GB9913932D0/en not_active Ceased
2000
- 2000-06-08 US US09/590,585 patent/US6900309B1/en not_active Expired - Fee Related
- 2000-06-13 WO PCT/IB2000/000789 patent/WO2000077018A2/en active Application Filing
- 2000-06-13 DZ DZ003168A patent/DZ3168A1/xx active
- 2000-06-13 NZ NZ516094A patent/NZ516094A/en unknown
- 2000-06-13 AR ARP000102905A patent/AR024345A1/es unknown
- 2000-06-13 EE EEP200100681A patent/EE200100681A/xx unknown
- 2000-06-13 HU HU0203419A patent/HUP0203419A3/hu unknown
- 2000-06-13 OA OA1200100332A patent/OA11968A/en unknown
- 2000-06-13 BR BR0011705-6A patent/BR0011705A/pt not_active IP Right Cessation
- 2000-06-13 IL IL14709800A patent/IL147098A0/xx unknown
- 2000-06-13 TR TR2001/03607T patent/TR200103607T2/xx unknown
- 2000-06-13 CA CA002379786A patent/CA2379786C/en not_active Expired - Fee Related
- 2000-06-13 JP JP2001503875A patent/JP2003502339A/ja not_active Ceased
- 2000-06-13 MX MXPA01013094A patent/MXPA01013094A/es active IP Right Grant
- 2000-06-13 EP EP00931495A patent/EP1185542A2/en not_active Withdrawn
- 2000-06-13 AU AU49443/00A patent/AU764106B2/en not_active Ceased
- 2000-06-13 CZ CZ20014397A patent/CZ20014397A3/cs unknown
- 2000-06-13 SK SK1819-2001A patent/SK18192001A3/sk unknown
- 2000-06-13 PL PL00354367A patent/PL354367A1/xx not_active Application Discontinuation
- 2000-06-13 EA EA200101203A patent/EA004861B1/ru not_active IP Right Cessation
- 2000-06-13 PE PE2000000582A patent/PE20010430A1/es not_active Application Discontinuation
- 2000-06-13 UY UY26204A patent/UY26204A1/es not_active Application Discontinuation
- 2000-06-13 AP APAP/P/2001/002361A patent/AP2001002361A0/en unknown
- 2000-06-13 HN HN2000000097A patent/HN2000000097A/es unknown
- 2000-06-13 KR KR1020017016127A patent/KR20020010707A/ko not_active Application Discontinuation
- 2000-06-13 CN CNB008130647A patent/CN1179970C/zh not_active Expired - Fee Related
- 2000-06-14 TN TNTNSN00133A patent/TNSN00133A1/fr unknown
- 2000-06-14 SV SV2000000100A patent/SV2001000100A/es unknown
- 2000-06-14 PA PA20008497001A patent/PA8497001A1/es unknown
- 2000-06-14 GT GT200000096A patent/GT200000096A/es unknown
- 2000-06-14 EC EC2000003531A patent/ECSP003531A/es unknown
2001
- 2001-12-11 IS IS6196A patent/IS6196A/is unknown
- 2001-12-12 MA MA26440A patent/MA26799A1/fr unknown
- 2001-12-12 ZA ZA200110208A patent/ZA200110208B/xx unknown
- 2001-12-13 HR HR20010927A patent/HRP20010927A2/hr not_active Application Discontinuation
- 2001-12-14 NO NO20016109A patent/NO20016109L/no not_active Application Discontinuation
2002
- 2002-01-08 BG BG06289A patent/BG106289A/xx unknown
- 2002-11-29 HK HK02108621A patent/HK1047111A1/xx not_active IP Right Cessation
2005
- 2005-01-24 US US11/042,582 patent/US20050124574A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HUP0203419A3 (en)	2005-02-28
CN1374966A (zh)	2002-10-16
EE200100681A (et)	2003-04-15
KR20020010707A (ko)	2002-02-04
HRP20010927A2 (en)	2003-04-30
CZ20014397A3 (cs)	2003-04-16
ECSP003531A (es)	2002-01-25
NO20016109D0 (no)	2001-12-14
CN1179970C (zh)	2004-12-15
SK18192001A3 (sk)	2003-04-01
AR024345A1 (es)	2002-10-02
OA11968A (en)	2006-04-17
US20050124574A1 (en)	2005-06-09
IL147098A0 (en)	2002-08-14
ZA200110208B (en)	2002-12-12
WO2000077018A2 (en)	2000-12-21
EA004861B1 (ru)	2004-08-26
BR0011705A (pt)	2002-03-26
TR200103607T2 (tr)	2002-10-21
HUP0203419A2 (hu)	2003-02-28
EA200101203A1 (ru)	2002-06-27
GT200000096A (es)	2001-12-06
GB9913932D0 (en)	1999-08-18
HK1047111A1 (en)	2003-02-07
NZ516094A (en)	2004-07-30
SV2001000100A (es)	2001-11-08
AU4944300A (en)	2001-01-02
MXPA01013094A (es)	2002-06-04
CA2379786A1 (en)	2000-12-21
PE20010430A1 (es)	2001-04-14
WO2000077018A3 (en)	2001-12-06
HN2000000097A (es)	2001-03-14
JP2003502339A (ja)	2003-01-21
UY26204A1 (es)	2001-01-31
DZ3168A1 (fr)	2000-12-21
PL354367A1 (en)	2004-01-12
CA2379786C (en)	2006-11-28
EP1185542A2 (en)	2002-03-13
PA8497001A1 (es)	2001-12-14
AU764106B2 (en)	2003-08-07
MA26799A1 (fr)	2004-12-20
US6900309B1 (en)	2005-05-31
NO20016109L (no)	2002-02-15
BG106289A (en)	2002-09-30
AP2001002361A0 (en)	2001-12-31
TNSN00133A1 (fr)	2002-05-30

Publication	Publication Date	Title
DE60026861D1 (de)	2006-05-11	Purin-derivate
ATE238336T1 (de)	2003-05-15	Purin-derivate
EE200100681A (et)	2003-04-15	Puriinderivaadid
NO20010743D0 (no)	2001-02-14	Antivirale indoloksoacetyl-piperazin-derivater
DE60119492D1 (de)	2006-06-14	Purinderivate
DE60103537D1 (de)	2004-07-01	Purinderivate
ATE263748T1 (de)	2004-04-15	Admantan-derivate
ATE293104T1 (de)	2005-04-15	Thiazolylamid-derivate
NO20015701L (no)	2001-11-22	5-Fenyl-pyrimidin-derivater
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
ATE273272T1 (de)	2004-08-15	Mevinolinderivate
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
DE60006703D1 (de)	2003-12-24	4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de)	2005-05-15	Resorcinderivate
DE60025348D1 (de)	2006-03-30	Ethansulfonyl-piperidin-derivate
NO20020212L (no)	2002-01-15	3-amino-2-benzyl-1-fenyl-propanderivater
DK1178984T3 (da)	2003-06-10	1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
DE59909774D1 (de)	2004-07-22	1-cycloalkylpyrazolyl-benzoyl-derivate
DK1090019T3 (da)	2005-02-07	Adenosinderivater